scholarly journals Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes

Gut ◽  
1998 ◽  
Vol 43 (2) ◽  
pp. 229-231 ◽  
Author(s):  
A R Hart ◽  
S Kudo ◽  
E H Mackay ◽  
J F Mayberry ◽  
W S Atkin

Background—Flat adenomas are non-exophytic with a flat top or central depression and histologically the depth of dysplastic tissue is never more than twice the mucosal thickness. Flat adenomas frequently contain severely dysplastic tissue, and may progress rapidly through the adenoma-carcinoma sequence. Flat lesions have never been described in a British asymptomatic population.Aims—To determine whether flat adenomas exist in an asymptomatic population participating in a large randomised controlled trial of flexible sigmoidoscopy screening.Patients—A total of 3000 subjects (aged 55–64 years) underwent screening by flexible sigmoidoscopy.Methods—All polyps were removed and sent for histology. The number of polyps with endoscopic and histological features of flat adenomas was recorded.Results—Three subjects had a total of four flat lesions—that is, one per 1000 people screened. Three contained severely dysplastic tissue, one a focus of adenocarcinoma. Three of the four lesions were less than 5 mm in size and the fourth was 15 mm in diameter.Conclusions—Flat lesions with severe dysplasia exist in the asymptomatic population. This has major implications for gastroenterologists who should be trained to identify them. Their existence is of importance to molecular biologists and epidemiologists investigating the aetiology of colorectal cancer.

BMJ ◽  
2009 ◽  
Vol 338 (may29 2) ◽  
pp. b1846-b1846 ◽  
Author(s):  
G. Hoff ◽  
T. Grotmol ◽  
E. Skovlund ◽  
M. Bretthauer ◽  

The Lancet ◽  
2010 ◽  
Vol 375 (9726) ◽  
pp. 1624-1633 ◽  
Author(s):  
Wendy S Atkin ◽  
Rob Edwards ◽  
Ines Kralj-Hans ◽  
Kate Wooldrage ◽  
Andrew R Hart ◽  
...  

2019 ◽  
Vol 10 (3) ◽  
pp. 244-252
Author(s):  
Simona Di Caro ◽  
Lucia Fini ◽  
Roser Vega ◽  
Konstantinos C Fragkos ◽  
Sunil Dolwani ◽  
...  

Background and objectivesThe UK bowel cancer screening programme (BCSP) has been established for the early detection of colorectal cancer offering colonoscopy to patients screened positive by faecal occult blood tests. In this multisite, prospective, randomised controlled trial, we aimed to compare the performance of Standard Definition Olympus Lucera (SD-OL) with Scope Guide and the High Definition Pentax HiLine (HD-PHL).Patients and methodsSubjects undergoing a colonoscopy as part of the UK National BCSP at four UK sites were randomised to an endoscopy list run using either SD-OL or HD-PHL. Primary endpoints were polyp and adenoma detection rate (PDR and ADR, respectively) as well as polyp size, morphology and histology characteristics.Results262 subjects (168 males, mean age 66.3±4.3 years) were colonoscoped (133 patients with HD-PHL while 129 with SD-OL). PDR and ADR were comparable within the two optical systems. The HD-PHL group resulted in a PDR 55.6% and ADR 43.6%; the SD-OL group had PDR 56.6% and ADR 45.7%. HD-PHL was significantly superior to SD-OL in detection of flat adenomas (18.6% vs 5.2%, p<0.001), but not detection of pedunculated or sessile polyps. Patient comfort, use of sedation and endoscopist perception of procedural difficulty resulted similar despite the use of Scope Guide with SD-OL.ConclusionPDR and ADR were not significantly different between devices. The high-resolution colonoscopy system HD-PHL may improve polyp detection as compared with standard resolution technology in detecting flat adenomas. This advantage may have clinically significant implications for missed lesion rates and post-colonoscopy interval colorectal cancer rates.


Trials ◽  
2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Aron Onerup ◽  
Eva Angenete ◽  
David Bock ◽  
Mats Börjesson ◽  
Monika Fagevik Olsén ◽  
...  

An amendment to this paper has been published and can be accessed via the original article.


Sign in / Sign up

Export Citation Format

Share Document